OMIDRIA Concentrate for solution for intraocular irrigation Ref.[51721] Active ingredients: Ketorolac Phenylephrine

Source: European Medicines Agency (EU)  Revision Year: 2023  Publisher: Rayner Surgical (Ireland) Limited, The Mill Enterprise Hub, Newtown Link Road, Drogheda, A92 CD3D, Co. Louth, Ireland, Tel +353 (0) 860592303, Fax +44 (0) 1903 751 470, Email GerKemmy@rayner.com

Product name and form

Omidria 10 mg/mL + 3 mg/mL concentrate for solution for intraocular irrigation.

Pharmaceutical Form

Concentrate for solution for intraocular irrigation.

Clear, colourless to slightly yellow, solution with a pH: 6.3 ±0.3.

Qualitative and quantitative composition

Each 4 mL of concentrate for solution in the vial contains phenylephrine hydrochloride equivalent to 40.6 mg (10.2 mg/mL) of phenylephrine and ketorolac trometamol equivalent to 11.5 mg (2.88 mg/mL) of ketorolac.

After dilution in 500 mL of irrigation solution, the solution contains 0.081 mg/mL of phenylephrine and of 0.023 mg/mL ketorolac.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Ketorolac

Ketorolac is a non-steroidal anti-inflammatory agent demonstrating analgesic and anti-inflammatory activity. Ketorolac inhibits the cyclo-oxygenase enzyme essential for biosynthesis of prostaglandins. Ketorolac has been shown to reduce prostaglandin levels in the aqueous humour after topical ophthalmic administration.

Phenylephrine

Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion.

List of Excipients

Citric acid monohydrate
Sodium citrate dihydrate
Sodium hydroxide (for pH adjustment)
Hydrochloric acid (for pH adjustment)
Water for injection

Pack sizes and marketing

Colourless 5 mL type I glass vial closed with a butyl rubber stopper and a polypropylene flip-off cap. Each single-use vial is packaged in a cardboard carton.

Pack size: multipack containing 10 (1 pack of 10) single-use vials.

Marketing authorization holder

Rayner Surgical (Ireland) Limited, The Mill Enterprise Hub, Newtown Link Road, Drogheda, A92 CD3D, Co. Louth, Ireland, Tel +353 (0) 860592303, Fax +44 (0) 1903 751 470, Email GerKemmy@rayner.com

Marketing authorization dates and numbers

EU/1/15/1018/001

Date of first authorisation: 28 July 2015
Renewal date: 23 July 2020

Drugs

Drug Countries
OMIDRIA Austria, Estonia, Croatia, Ireland, Italy, Lithuania, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.